ETON insider trading

Open-market stock trades by Eton Pharmaceuticals (ETON) executives and directors: who bought or sold, how many shares, at what price and when.

ETON insider trades

DateInsiderRoleTradeSharesPriceValue
Oct 6, 2026Krempa DavidChief Business OfficerSell4,166$55.07$229.41K
Aug 28, 2026MAIER PAUL VdirectorSell36,387$58.64$2.13M
Aug 28, 2026MAIER PAUL VdirectorSell13,485$60.21$811.93K
Aug 28, 2026MAIER PAUL VdirectorSell128$61.77$7.91K
Aug 24, 2026Krempa DavidChief Business OfficerSell25,000$65.07$1.63M
Aug 19, 2026BRYNJELSEN SEANPresident & CEOSell8,978$62.65$562.47K
Aug 20, 2026BRYNJELSEN SEANPresident & CEOSell47,307$60.17$2.85M
Aug 20, 2026BRYNJELSEN SEANPresident & CEOSell36,373$61.11$2.22M
Aug 20, 2026BRYNJELSEN SEANPresident & CEOSell7,342$62.12$456.09K
Jul 14, 2026Opaleye Management Inc.10 percent ownerSell15,000$37.54$563.15K
Jul 14, 2026Opaleye Management Inc.10 percent ownerSell13,315$37.54$499.89K
Jul 14, 2026Opaleye Management Inc.10 percent ownerSell15,000$37.54$563.15K
Jul 14, 2026Opaleye Management Inc.10 percent ownerSell13,315$37.54$499.89K
Jul 2, 2026Opaleye Management Inc.10 percent ownerSell65,000$37.39$2.43M
Jul 6, 2026Opaleye Management Inc.10 percent ownerSell10,000$38.00$380.00K
Jul 7, 2026Opaleye Management Inc.10 percent ownerSell20,000$38.37$767.46K
Jul 2, 2026Opaleye Management Inc.10 percent ownerSell25,000$37.39$934.63K
Jul 7, 2026Opaleye Management Inc.10 percent ownerSell6,685$38.37$256.52K
Jun 17, 2026Adams Jennifer McKiedirectorSell50,000$32.48$1.62M
May 28, 2026BRYNJELSEN SEANPresident & CEOSell119,852$31.88$3.82M
May 28, 2026BRYNJELSEN SEANPresident & CEOSell148$32.67$4.84K
May 22, 2026Krempa DavidChief Business OfficerSell32,963$33.22$1.10M
May 22, 2026Krempa DavidChief Business OfficerSell9,315$33.88$315.59K
May 22, 2026Krempa DavidChief Business OfficerSell519$35.00$18.16K
May 27, 2026Krempa DavidChief Business OfficerSell19,679$31.47$619.37K
May 26, 2026Krempa DavidChief Business OfficerSell37,524$31.49$1.18M

Updated 2026-11-03 11:33 UTC